Nocturnal behaviours, stridor and recurrent respiratory failure in anti-IgLON5 disease. (PubMed, Pract Neurol) - Sep 30, 2026 - "Her condition partially improved after intravenous methylprednisolone and then rituximab, and she remains under follow-up. Patients with treatment-resistant sleep-disordered breathing, laryngeal dysfunction and nocturnal motor behaviours should be tested for anti-IgLON5 disease."
Journal • CNS Disorders • Epilepsy • Immunology • Movement Disorders • Otorhinolaryngology • Respiratory Diseases • Sleep Apnea • Sleep Disorder
|
|
Apinya Kroeksattayaporn; Athiwat Tripipitsiriwat; Jindapa Srikajon; Jiraporn Jitprapaikulsan; Thanakrit Tanrattanakorn
|